-+ 0.00%
-+ 0.00%
-+ 0.00%

ORUKA THERAPEUTICS - ORKA-002 SHOWS 75-80 DAYS HALF-LIFE SUPPORTING TWICE-YEARLY DOSING IN PSORIASIS

Reuters·01/12/2026 12:00:03

Please log in to view news